EarningsQ3 2023 Earnings Report

Mirum Pharmaceuticals (08D) Q3 2023 Earnings Report

0 Followers

DE:08D Q3 2023 EPS Results

Actual EPS-€0.51

Consensus EPS-€0.56

Beat/MissBeat by +€0.05

One Year Ago EPS-€0.91

Actual Revenue€42.59M

Expected Revenue€34.45M

Beat/MissBeat by +€8.14M

YoY Revenue Growth+154.13%

QuarterQ3 2023

Date11/02/2023

TimeAfter Close

Conference CallThursday, November 2, 2023

DE:08D Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

DE:08D Q3 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-0.44 / -	0.045	―
Aug 05, 2026	2026 (Q2)	-0.66 / -0.95	-0.107	-783.33% (-0.84)
May 06, 2026	2026 (Q1)	-0.33 / -11.99	-0.268	-4376.67% (-11.72)
Feb 25, 2026	2025 (Q4)	0.05 / -0.09	-0.437	79.59% (+0.35)
Nov 04, 2025	2025 (Q3)	-0.12 / 0.04	-0.268	116.67% (+0.31)
Aug 06, 2025	2025 (Q2)	-0.29 / -0.11	-0.464	76.92% (+0.36)
May 07, 2025	2025 (Q1)	-0.29 / -0.27	-0.482	44.44% (+0.21)
Feb 26, 2025	2024 (Q4)	-0.23 / -0.44	-0.562	22.22% (+0.12)
Nov 12, 2024	2024 (Q3)	-0.40 / -0.27	-0.509	47.37% (+0.24)
Aug 07, 2024	2024 (Q2)	-0.42 / -0.46	-1.731	73.20% (+1.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed